Literature DB >> 20016960

Pheno- and genotypic features of Epstein-Barr virus associated B-cell lymphoproliferations in peripheral T-cell lymphomas.

Gábor Smuk1, Arpád Illés, Katalin Keresztes, László Kereskai, Balázs Márton, Zsófia Nagy, Agnes Lacza, László Pajor.   

Abstract

Among the 300 peripheral T-cell lymphomas (PTCL) searched for EBV positive non-resting B-cells by EBER in situ hybridization 12 have been identified with various forms of EBV-driven B-cell proliferation. This could be categorized into three major forms. i. In the first form scattered immature, mononuclear B-cells of immuno-, centroblastic type with CD20+. CD30+ CD45+, LMP1+ phenotype, reactive appearance and polyclonal immunoglobulin heavy chains gene rearrangement (IgH-R) were admixed to the PTCL cells. ii. The second form mimicked diffuse large B-cell lymphoma as homogenous sheets, largely demarcated from the PTCL, of mononuclear, immature B-cell of CD20+, CD30+, CD45+, LMP1+, EBNA-2+ phenotype but with lack of monoclonal IgH-R were present. iii. In the third form scattered Hodgkin-Reed-Sternberg (HRS) type of cells were noticed which exhibited the CD15+/-, CD20-/+, CD30+, CD45-, LMP1+, EBNA-2- phenotype and in 50% showed clonal IgH gene rearrangement in whole tissue DNA extract. The IgH associated transcription factors' (OCT2, BOB.1/OBF.1, PU.1) expression patterns in these cells corresponded to those of HRS cells in cHL. Based on analysis of 65 PTCLs, we have identified in the positive cases a highly significant increase of EBV+ small, reactive, resting B-cell compartment (75.9 / 100 HPF in PTCL vs. 1.5 / 100 HPF in control lymph nodes) likely to be due to the decreased immune surveillance. This progressive accumulation of EBV+ by-stander B-cell population in PTCLs might be the source of various B-cell proliferations, which in any form represent major diagnostic pitfalls and require a careful differential diagnostic procedure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20016960     DOI: 10.1007/s12253-009-9233-2

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  18 in total

1.  Peripheral T-cell lymphoma complicated by a proliferation of large B cells.

Authors:  J P Higgins; M van de Rijn; C D Jones; J L Zehnder; R A Warnke
Journal:  Am J Clin Pathol       Date:  2000-08       Impact factor: 2.493

Review 2.  Persistence of the Epstein-Barr virus and the origins of associated lymphomas.

Authors:  David A Thorley-Lawson; Andrew Gross
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

3.  Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified.

Authors:  Andreas Zettl; Seung-Sok Lee; Thomas Rüdiger; Petr Starostik; Mirella Marino; Thomas Kirchner; Michaela Ott; Hans Konrad Müller-Hermelink; German Ott
Journal:  Am J Clin Pathol       Date:  2002-03       Impact factor: 2.493

4.  Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays.

Authors:  Ryan C McCune; Sergei I Syrbu; Mohammad A Vasef
Journal:  Mod Pathol       Date:  2006-04-28       Impact factor: 7.842

5.  Hodgkin's disease and peripheral T-cell lymphoma: composite lymphoma with evidence of Epstein-Barr virus infection.

Authors:  G Niedobitek; I Baumann; T Brabletz; R Lisner; C Winkelmann; G Helm; T Kirchner
Journal:  J Pathol       Date:  2000-08       Impact factor: 7.996

6.  Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection.

Authors:  L Quintanilla-Martinez; F Fend; L R Moguel; L Spilove; M W Beaty; D W Kingma; M Raffeld; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1999-10       Impact factor: 6.394

7.  CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells.

Authors:  Kaaren K Reichard; Erich J Schwartz; John P Higgins; Balasubramanian Narasimhan; Roger A Warnke; Yasodha Natkunam
Journal:  Mod Pathol       Date:  2006-03       Impact factor: 7.842

8.  Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases.

Authors:  Supaporn Suwiwat; Jintana Pradutkanchana; Takafumi Ishida; Winyou Mitarnun
Journal:  J Clin Virol       Date:  2007-11-09       Impact factor: 3.168

9.  Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas.

Authors:  P Korbjuhn; I Anagnostopoulos; M Hummel; M Tiemann; F Dallenbach; M R Parwaresch; H Stein
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

10.  EBER oligonucleotide RNA in situ hybridization in EBV associated neoplasms.

Authors:  T Tornóczky; G Kelényi; L Pajor
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

View more
  4 in total

1.  New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2010-06-02       Impact factor: 0.196

2.  Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.

Authors:  Gerald G Wulf; Bettina Altmann; Marita Ziepert; Francesco D'Amore; Gerhard Held; Richard Greil; Olivier Tournilhac; Thomas Relander; Andreas Viardot; Martin Wilhelm; Christian Wilhelm; Antonio Pezzutto; Josee M Zijlstra; Eric Van Den Neste; Pieternella J Lugtenburg; Jeanette K Doorduijn; Michel van Gelder; Gustaaf W van Imhoff; Florian Zettl; Friederike Braulke; Maike Nickelsen; Bertram Glass; Andreas Rosenwald; Philippe Gaulard; Markus Loeffler; Michael Pfreundschuh; Norbert Schmitz; Lorenz Trümper
Journal:  Leukemia       Date:  2020-05-07       Impact factor: 11.528

Review 3.  Epigenetic regulation of EBV and KSHV latency.

Authors:  Horng-Shen Chen; Fang Lu; Paul M Lieberman
Journal:  Curr Opin Virol       Date:  2013-04-16       Impact factor: 7.090

4.  Aggressive Subcutaneous Panniculitis-Like CD30+ Peripheral T-Cell Lymphoma with Diffuse EBER Expression.

Authors:  Amandeep Aneja; Raghava LevakaVeera; Viren Patel; Ashish Bains
Journal:  Case Rep Hematol       Date:  2014-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.